Sign Up to like & get
recommendations!
0
Published in 2018 at "Clinical Drug Investigation"
DOI: 10.1007/s40261-018-0673-x
Abstract: Background and ObjectiveBatroxobin, a snake venom thrombin-like enzyme, converts fibrinogen into fibrin by cleaving fibrinopeptide A. It is used for hemostasis; however, the supply of native batroxobin is limited. Therefore, we developed a recombinant batroxobin…
read more here.
Keywords:
recombinant batroxobin;
group;
study;
compared placebo ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
1
Published in 2020 at "CNS Drugs"
DOI: 10.1007/s40263-020-00715-7
Abstract: Background Ubrogepant is a small molecular calcitonin gene–related peptide receptor antagonist that is used for the acute treatment of migraine. Objective The aim was to conduct a meta-analysis to systematically evaluate the efficacy and safety…
read more here.
Keywords:
episodic migraine;
migraine;
treatment;
randomized clinical ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2022 at "CNS Drugs"
DOI: 10.1007/s40263-022-00916-2
Abstract: The objective of this study was to determine which symptoms measured by the Patient Health Questionnaire (PHQ-9) and Montgomery-Asberg Depression Rating Scale (MADRS) improve in those treated with esketamine nasal spray in combination with oral…
read more here.
Keywords:
placebo plus;
treated esketamine;
phq;
esketamine plus ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "European urology"
DOI: 10.1016/j.eururo.2018.06.037
Abstract: We tested whether intervention with atorvastatin affects the prostate beneficially compared with placebo in men with prostate cancer in a randomized clinical trial. A total of 160 statin-naïve prostate cancer patients scheduled for radical prostatectomy…
read more here.
Keywords:
placebo;
compared placebo;
atorvastatin;
prostate cancer ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "International journal of surgery"
DOI: 10.1016/j.ijsu.2019.04.007
Abstract: BACKGROUND Although numerous treatments exist for fecal incontinence (FI), no consensus exists on the best treatment strategy. The aim was to review the literature and to compare the clinical outcomes and effectiveness of treatments available…
read more here.
Keywords:
faecal incontinence;
comparing treatments;
incontinence;
compared placebo ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2020 at "Journal of anxiety disorders"
DOI: 10.1016/j.janxdis.2020.102188
Abstract: OBJECTIVE Test changes in perceived coping efficacy, negative self-statements, and interpretive biases to threat during treatment as potential mediators of the relationship between randomly assigned treatment conditions and long-term anxiety follow-ups. Age at randomization was…
read more here.
Keywords:
intervention;
anxiety;
treatment;
anxiety outcomes ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Psychoneuroendocrinology"
DOI: 10.1016/j.psyneuen.2019.104384
Abstract: BACKGROUND Occupational burnout is both a serious health concern at both public and individual levels. Treatment options are psychopharmacological, psychological and physical activity-related interventions. Here, we tested whether, compared to placebo, omega-3-polyunsaturated fatty acids (O3PUFAs)…
read more here.
Keywords:
fatty acids;
compared placebo;
morning;
placebo ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Journal of Perinatology"
DOI: 10.1038/s41372-019-0476-9
Abstract: Among nonventilated preterm infants, who are less than 32 weeks of gestation or with birth weight less than 1501 g, undergoing an eye examination to detect retinopathy of prematurity (ROP) or heel lancing, will a…
read more here.
Keywords:
morphine compared;
efficacy;
compared placebo;
preterm infants ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2025 at "Scientific Reports"
DOI: 10.1038/s41598-025-09807-0
Abstract: To compare efficacy and safety of glucagon-like peptide-1 receptor agonists (GLP-1RAs) in subjects with type 2 diabetes (T2DM). Electronic databases were searched from inception to 2nd October 2024 for randomised controlled trials comparing GLP-1RAs treating…
read more here.
Keywords:
glp;
compared placebo;
network meta;
safety ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2024 at "Blood Pressure"
DOI: 10.1080/08037051.2024.2424824
Abstract: Abstract Background Resistant hypertension (RH) is linked to higher risks of cardiovascular events and there remains an unmet therapeutic need driven by pathophysiologic pathways unaddressed by guideline-recommended therapy. Whilst spironolactone is considered the preferred fourth-line…
read more here.
Keywords:
pharmacotherapy;
drug;
profile;
compared placebo ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2024 at "Journal of the International Society of Sports Nutrition"
DOI: 10.1080/15502783.2024.2419388
Abstract: ABSTRACT Background This study aimed to investigate the impact of Urolithin A (UA) on muscle endurance, muscle strength, inflammatory levels, oxidative stress, and protein metabolism status in resistance-trained male athletes. Method An 8-week randomized, double-blind,…
read more here.
Keywords:
muscle;
oxidative stress;
group;
placebo ... See more keywords